miR-22 represses cancer progression by inducing cellular senescence

The microRNA miR-22 targets CDK6, SIRT1, and Sp1—genes involved in regulation of the senescence program—to suppress cell growth and proliferation.

[1]  K. Belguise,et al.  FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells , 2005, Oncogene.

[2]  C. Croce,et al.  microRNAs: Master regulators as potential therapeutics in cancer. , 2011, Annual review of pharmacology and toxicology.

[3]  S. Lowe,et al.  Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.

[4]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[5]  P. Pandolfi,et al.  The Proto-Oncogene LRF Is under Post-Transcriptional Control of MiR-20a: Implications for Senescence , 2008, PloS one.

[6]  A. Silahtaroglu,et al.  Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver , 2007, Nucleic acids research.

[7]  S. Lowe,et al.  Senescence comes of age , 2005, Nature Medicine.

[8]  I. Pogribny,et al.  Down‐regulation of the microRNAs miR‐34a, miR‐127, and miR‐200b in rat liver during hepatocarcinogenesis induced by a methyl‐deficient diet , 2009, Molecular carcinogenesis.

[9]  Shu Zheng,et al.  Epidermal growth factor receptor-regulated miR-125a-5p – a metastatic inhibitor of lung cancer , 2009, The FEBS journal.

[10]  Y. Akao,et al.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. , 2006, Biological & pharmaceutical bulletin.

[11]  C. Schmitt.  Cellular senescence and cancer treatment. , 2007, Biochimica et biophysica acta.

[12]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[13]  Nadav S. Bar,et al.  miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics , 2010, PloS one.

[14]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Moustakas,et al.  Sp1 Plays a Critical Role in the Transcriptional Activation of the Human Cyclin-dependent Kinase Inhibitor p21 WAF1/Cip1 Gene by the p53 Tumor Suppressor Protein* , 2001, The Journal of Biological Chemistry.

[16]  Naoto Tsuchiya,et al.  Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells , 2007, Proceedings of the National Academy of Sciences.

[17]  W. Gu,et al.  How does SIRT1 affect metabolism, senescence and cancer? , 2009, Nature Reviews Cancer.

[18]  Y. Ouchi,et al.  Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells , 2006, Oncogene.

[19]  Meng Ling Choong,et al.  MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. , 2007, Experimental hematology.

[20]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[21]  Yusuke Yamamoto,et al.  Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  Ying Sun,et al.  SIRT1 Overexpression Antagonizes Cellular Senescence with Activated ERK/S6k1 Signaling in Human Diploid Fibroblasts , 2008, PloS one.

[23]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[24]  M. Chopp,et al.  MiR-146b-5p Suppresses EGFR Expression and Reduces In Vitro Migration and Invasion of Glioma , 2010, Cancer investigation.

[25]  A. Moustakas,et al.  Sp 1 Plays a Critical Role in the Transcriptional Activation of the Human Cyclin-dependent Kinase Inhibitor p 21 WAF 1 / Cip 1 Gene by the p 53 Tumor Suppressor Protein * , 2001 .

[26]  Konstantinos N. Malizos,et al.  Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory Networks , 2008, PloS one.

[27]  J. Campisi.  Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.

[28]  Chengzhong Xing,et al.  Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical Significance , 2010, Journal of Gastrointestinal Surgery.

[29]  Anindya Dutta,et al.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. , 2007, Genes & development.

[30]  Raquel Díaz,et al.  Deregulated expression of miR‐106a predicts survival in human colon cancer patients , 2008, Genes, chromosomes & cancer.

[31]  P. Distefano,et al.  Inhibition of SIRT1 Catalytic Activity Increases p53 Acetylation but Does Not Alter Cell Survival following DNA Damage , 2006, Molecular and Cellular Biology.

[32]  William C Hahn,et al.  Rules for making human tumor cells. , 2002, The New England journal of medicine.

[33]  Borja Saez,et al.  Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth , 2008, Molecular Cancer Research.

[34]  Haoming Zhang,et al.  miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes , 2008, Nucleic acids research.

[35]  Carmen Socaciu,et al.  Kinetics of apoptotic markers in exogeneously induced apoptosis of EL4 cells , 2002, Journal of cellular and molecular medicine.

[36]  J. Ricarte-Filho,et al.  Effects of let-7 microRNA on Cell Growth and Differentiation of Papillary Thyroid Cancer. , 2009, Translational oncology.

[37]  G. Peters,et al.  CDK4 and CDK6 Delay Senescence by Kinase-Dependent and p16INK4a-Independent Mechanisms , 2007, Molecular and Cellular Biology.

[38]  T. Ide,et al.  G-tail telomere HPA: simple measurement of human single-stranded telomeric overhangs , 2005, Nature Methods.

[39]  Kathryn A. O’Donnell,et al.  Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.

[40]  Xian-Ming Chen,et al.  Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation , 2010, British journal of haematology.

[41]  R. Sachidanandam,et al.  A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells , 2007 .

[42]  Didier Picard,et al.  miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA , 2009, Molecular and Cellular Biology.

[43]  J. Haier,et al.  MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. , 2010, European journal of cancer.

[44]  J. Catania,et al.  Involvement of Rb family proteins, focal adhesion proteins and protein synthesis in senescent morphogenesis induced by hydrogen peroxide. , 2000, Journal of cell science.

[45]  H. Namba,et al.  Oncogenic role of miR‐17‐92 cluster in anaplastic thyroid cancer cells , 2008, Cancer science.

[46]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  P. Adams.  Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. , 2007, Gene.

[48]  Zicai Liang,et al.  Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein , 2010, Oncogene.

[49]  H. Stein,et al.  Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.

[50]  I. Roninson,et al.  Regulation of Sp1 by cell cycle related proteins , 2008, Cell cycle.

[51]  Yi Tie,et al.  Downregulation of CCND1 and CDK6 by miR‐34a induces cell cycle arrest , 2008, FEBS letters.

[52]  N. Jamieson,et al.  Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. , 2009, Biochimica et biophysica acta.

[53]  Y. Mizuguchi,et al.  MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. , 2009, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[54]  J. Campisi,et al.  Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo , 2009, Nature Protocols.

[55]  Sandy Chang,et al.  Telomere dysfunction and tumour suppression: the senescence connection , 2008, Nature Reviews Cancer.

[56]  Yi Tie,et al.  miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. , 2009, Cancer letters.

[57]  Yiguo Jiang,et al.  miR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[58]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[59]  C. Croce,et al.  Specific microRNAs are downregulated in human thyroid anaplastic carcinomas , 2007, Oncogene.

[60]  E. Hara,et al.  Cellular senescence: Its role in tumor suppression and aging , 2009, Cancer science.

[61]  Domenico Coppola,et al.  MicroRNA-155 Regulates Cell Survival, Growth, and Chemosensitivity by Targeting FOXO3a in Breast Cancer* , 2010, The Journal of Biological Chemistry.

[62]  Haifan Lin,et al.  MicroRNAs: key regulators of stem cells , 2009, Nature Reviews Molecular Cell Biology.

[63]  R. Strair,et al.  Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression. , 2010, Biochemical and biophysical research communications.

[64]  Sonal Patel,et al.  A single-molecule method for the quantitation of microRNA gene expression , 2005, Nature Methods.

[65]  S. Haferkamp,et al.  The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence , 2009, Aging.